Author correction: prostate cancer therapy personalization via multi-modal deep learning on randomized phase iii clinical trials

HIGHLIGHTS

• who: Andre Esteva from the in partnership with Seoul National University Bundang Hospital have published the research work: Author Correction: Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials, in the Journal: (JOURNAL)

SUMMARY

Published in partnership with Seoul National University Bundang Hospital In the interest of transparency and clinical relevance, the authors repeated the evaluation of model performance in the validation set after removing any cases with post-treatment prostate tissue. This results in a slightly smaller cohort (n=931) for validation, compared to the 20 . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.